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Innate lymphoid cells (ILCs) are a recently recog-
nized group of lymphocytes that have important
functions in protecting epithelial barriers against
infections and in maintaining organ homeostasis.
ILCs have been categorized into three distinct
groups, transcriptional circuitry and effector func-
tions of which strikingly resemble the various T
helper cell subsets. Here, we identify a common,
Id2-expressing progenitor to all interleukin 7 re-
ceptor-expressing, ‘‘helper-like’’ ILC lineages, the
CHILP. Interestingly, the CHILP differentiated into
ILC2 and ILC3 lineages, but not into conventional
natural killer (cNK) cells that have been considered
an ILC1 subset. Instead, the CHILP gave rise to a
peculiar NKp46+ IL-7Ra+ ILC lineage that required
T-bet for specification and was distinct of cNK
cells or other ILC lineages. Such ILC1s copro-
duced high levels of IFN-g and TNF and pro-
tected against infections with the intracellular
parasite Toxoplasma gondii. Our data significantly
advance our understanding of ILC differentia-
tion and presents evidence for a new ILC lineage
that protects barrier surfaces against intracellular
infections.340 Cell 157, 340–356, April 10, 2014 ª2014 Elsevier Inc.INTRODUCTION
Over the last years, several innate lymphocyte populations have
been identified, collectively referred to as innate lymphoid cells
(ILCs) (Spits et al., 2013). In contrast to T and B cells, ILCs do
not express recombining, antigen-specific receptors and are
substantially represented at barrier surfaces such as the lamina
propria of small intestine and colon. Based on the expression of
lineage-defining transcription factors and on distinct cytokine
profiles, three groups of ILCs can be discriminated. Group 1
ILCs (ILC1s) are believed to express the transcription factor
T-bet and produce the ‘‘type 1’’ cytokine IFN-g, a potent stimu-
lator of mononuclear phagocytes for antimicrobial activity effec-
tively controlling intracellular infections. ILC2 differentiation and
maintenance require the transcription factor GATA-3 (Hoyler
et al., 2012; Mjo¨sberg et al., 2012; Yagi et al., 2014). ILC2s pro-
duce copious amounts of the ‘‘type 2’’ cytokines IL-5 and IL-13
(Moro et al., 2010; Neill et al., 2010) and play important roles in
immunity to helminth infections (Neill et al., 2010) and in the path-
ogenesis of asthma and allergies (Nussbaum et al., 2013).
RORgt-expressing ILC3s are an important source of the ‘‘type
17’’ cytokines IL-22 and IL-17A. ILC3s are absolutely required
for the defense against intestinal bacterial infections (Diefen-
bach, 2013) and provide ‘‘help’’ to marginal zone B cells (Magri
et al., 2014).
With the notable exception of cNK cells, ILCs share various
phenotypic markers such as expression of IL-7Ra and of the
receptor tyrosine kinase Kit. In addition, all ILC subsets express
the transcriptional regulator inhibitor of DNA binding 2 (Id2), an
antagonist of E proteins (Hoyler et al., 2012; Kee, 2009). Genetic
deletion of Id2 cripples the development of all known ILC line-
ages (Moro et al., 2010; Yokota et al., 1999). Collectively, these
data may argue that a common, Id2-expressing progenitor to
ILC lineages may exist which is one of the important unresolved
problems of ILC biology. Characterization of such a progenitor
would allow to probe the signals required to specify the various
ILC fates which are currently unknown.
While ILC2s and ILC3s are well characterized, ILC1s are not
well-defined. It has been proposed that ILC1s should be T-bet-
dependent producers of ‘‘type 1’’ cytokines that are required to
control intracellular infections (Spits et al., 2013). ILC1s are
currently believed to contain IL-7Ra cNK cells, intraepithelial
ILC1s (Fuchs et al., 2013) and ‘‘ex-RORgt+’’ ILC3s (Bernink
et al., 2013; Klose et al., 2013; Vonarbourg et al., 2010), the latter
are of the ILC3 lineagebut phenotypically hard todistinguish from
ILC1s. It is currently unclear whether a non-NK, IL-7Ra+ ILC1
lineage exists and whether cNK cells are of the same lineage as
the IL-7Ra+ ILC subsets. Conventional NK cells differ from the
other ILC subsets, because their specification may be indepen-
dent of Id2 (Boos et al., 2007). NK cells coexpress the T-box tran-
scription factors Eomesodermin (Eomes) and T-bet (Gordon
et al., 2012) but T-bet deficiency leads only to a mild reduction
of NK cell numbers (Townsend et al., 2004), whereas Eomes-
deficient mice are devoid of cNK cells (Gordon et al., 2012).
We have identified a Lin Id2+ IL-7Ra+ CD25 integrin a4b7
+
progenitor in the bone marrow and the fetal liver that, on a clonal
level, gives rise to all ILC lineages in vitro and in vivo but had no
appreciable potential to differentiate into B and T cells or cNK
cells. This may indicate that IL-7Ra cNK cells follow a distinct
differentiation path and constitute cytotoxic ILCs distinct from
IL-7Ra+ helper-like ILCs. While such progenitor to all helper-
like ILCs (CHILP) did not differentiate into cNK cells, it gave
rise to a T-bet+ Eomes IL-7Ra+ non-NK ILC1 lineage. We
show that the intestinal lamina propria contains a NKp46+
NK1.1+ Eomes RORgt-fate map (fm) T-bet+, poorly cytotoxic
ILC1 lineage distinct from cNK cells which required T-bet for
development. Interestingly, ILC1s, but not cNK cells, were the
main producers of IFN-g and TNF in response to IL-12 and to
intestinal infection with an intracellular parasite, Toxoplasma
(T.) gondii. Thus, our data reveal additional layers of ILC effector
fates and presents evidence for an ILC1 lineage distinct from
cNK cells that protects barrier surfaces against intracellular
infections.
RESULTS
Identification of an Id2-Expressing Lymphoid Progenitor
We used mice with an Id2 reporter allele (Id2Gfp/+) to track pro-
genitors of ILCs. In the bone marrow of adult mice, a discernable
Id2+ population that does not express any markers of mature
hematopoietic lineages (i.e., Lineage negative, Lin) was present
(Figure 1A and Figure S1A available online). Lin Id2+ cells
expressed integrin a4b7 and could be further segregated into
a CD25 and a CD25+ subset. CD25+ a4b7
+ cells represented
the previously identified ILC2P uniformly expressing the IL-33R
(Figure 1B) (Hoyler et al., 2012). Both, the CD25 a4b7
+ and theCD25+ a4b7
+ subsets expressed IL-7Ra (CD127), a receptor
found on all ILCs (except cNK cells) and by lymphoid progenitors
(Figures 1A and S1A). The Lin Id2+ IL-7Ra+ CD25 a4b7
+ popu-
lation expressed markers also found on the common lymphoid
progenitor (CLP) such as the receptor tyrosine kinase Kit
(CD117), Sca-1, CD244 (2B4), and CD27, and both populations
were CD25 (Figure 1B). Nevertheless, Lin Id2+ IL-7Ra+
CD25 a4b7
+ cells are distinct from the CLP because they did
not display on the cell surface CD93 (Figure 1B) or Flt3 (Fms-
related tyrosine kinase 3) (Figure S1A), uniformly found on the
CLP (Fathman et al., 2011; Karsunky et al., 2008) that does not
express Id2 (Hoyler et al., 2012). Lin Id2+ IL-7Ra+ CD25
a4b7
+ cells are CD122 (Figure 1B), distinguishing them from
committed NK cell progenitors (rNKP) (Fathman et al., 2011)
which were largely Id2 negative (Figure S1B) as reported previ-
ously (Boos et al., 2007).
If Lin Id2+ IL-7Ra+ CD25 a4b7
+ cells are ILC progenitors,
they should not express the lineage-defining transcription fac-
tors of mature ILCs. Importantly, Lin Id2+ IL-7Ra+ CD25
a4b7
+ cells were negative for RORgt, T-bet, and Eomes and ex-
pressed intermediate levels of GATA-3 comparable to the CLP,
but not to the high GATA-3 profile found in the ILC2 lineage (Fig-
ure 1C) (Hoyler et al., 2012). We also interrogated expression of a
potential Id2 target gene, promyelocytic leukemia zinc finger
(PLZF) (Verykokakis et al., 2013), which is essential for the devel-
opment of invariant NKT cells and confers innate properties
to conventional CD4 T cells. Interestingly, a subset of Lin Id2+
IL-7Ra+ CD25 a4b7
+ cells expressed PLZF (Figure 1C).
As transcription of PLZF was shown to be controlled by Id2 (Ver-
ykokakis et al., 2013), the PLZF+ population may be downstream
of PLZF Lin Id2+ IL-7Ra+ CD25 a4b7
+ cells and may have
restricted developmental potential (Constantinides et al.,
2014). Development of all recognized ILC lineages requires
IL-7R signaling and therefore, we wondered if the Lin Id2+
IL-7Ra+ CD25 a4b7
+ population is IL-7R-dependent. While
differentiation or maintenance of the ILC2P required IL-7R
signaling, there was only a small (but reproducible) reduction
of the CLP and the Lin Id2+ IL-7Ra+ CD25 a4b7
+ population
in Il7ra/ bone marrow (Figure 1D).
Lin Id2+ IL-7Ra+ CD25 a4b7
+ Cells, a Common
Progenitor to the ILC2, ILC3, and aNon-NK ILC1 Lineage
To probe the differentiation potential of Lin Id2+ IL-7Ra+ CD25
a4b7
+ cells, we highly purified these cells and adoptively trans-
ferred them into alymphoid mice. As a comparison, we injected
CLPs (Lin Id2 IL-7Ra+ a4b7
 Flt3+ cells) or ILC2Ps (Lin Id2+
IL-7Ra+ CD25+ a4b7
+ Flt3 cells). Six to nine weeks after transfer,
donor-derivedcellswere analyzed in various organs.CLPsgener-
ated Lin+ (T and B cells) and Lin progeny in all organs tested
(Figures 2A, 2B, S2A, and S2B), whereas the ILC2P gave rise to
GATA-3high ILC2s, but not other ILC lineages (Figure S2C) as pre-
viously demonstrated (Hoyler et al., 2012). Interestingly, progeny
of Lin Id2+ IL-7Ra+ CD25 a4b7
+ cells was only found inmucosal
organs such as small intestine and liver (Figures 2A and 2B) and
only very few donor-derived cells were present in spleen or
thymus (Figures S2A and S2B). In addition, Lin Id2+ IL-7Ra+
CD25 a4b7
+ cells had no B or T cell potential (Figures 2A, S2A,
and S2B). Strikingly, Lin Id2+ IL-7Ra+ CD25 a4b7
+ cellsCell 157, 340–356, April 10, 2014 ª2014 Elsevier Inc. 341
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Figure 1. Characterization of an Id2-Expressing Lymphoid Progenitor Distinct from the CLP and ILC2P
(A) Representative analysis of Id2Gfp/+ bonemarrow cells. Histogramswere electronically gated on Lin Id2+ CD25 a4b7
+ cells (red) or Lin Id2+ CD25+ a4b7
+ cells
(blue). Numbers denote percent of cells in the indicated area.
(B and C) Id2Gfp/+ (B) or C57BL/6 (C) bone marrow cells were costained for CD45, Lineage markers, IL-7Ra, Flt3, integrin a4b7, CD25, and antibodies specific for
the indicated markers. Histograms depict expression of the indicated cell surface markers (B) or transcription factors (C) by CLP, ILC2P and Lin Id2+ IL-7Ra+
CD25 a4b7
+ cells (see Figure S1). NK cells (NK1.1+ cells) were plotted as positive control for CD122 staining.
(D) Absolute cell numbers (mean ± SEM; n = 3) of the indicated precursor populations.
*p < 0.05; CLP, common lymphoid progenitor; ILC2P, ILC2 precursor; Lin, Lineage; ns, not significant. Data are representative of at least three independent
experiments.differentiated into GATA-3+ ILC2s, and into the two principal
RORgt+ ILC3 populations, CCR6+ and CCR6 ILC3s (Figures
2A and S2C). Within the CCR6+ RORgt+ population, a CD4+ (rep-
resenting lymphoid tissue inducer [LTi] cells) and a CD4 subset342 Cell 157, 340–356, April 10, 2014 ª2014 Elsevier Inc.could be discriminated and CCR6 RORgt+ ILCs contained
a NKp46+ and a NKp46 subset (Figure 2A). Thus, Lin Id2+ IL-
7Ra+ CD25 a4b7
+ cells differentiated into all recognized subsets
of RORgt+ ILC3s (Klose et al., 2013).
We investigated if Lin Id2+ IL-7Ra+ CD25 a4b7
+ cells and
CLPs can also differentiate into bone-marrow-resident ILC2Ps.
Among CLP-derived Lin IL-7Ra+ a4b7
+ Flt3 cells, both Id2+
CD25 (ILC progenitors) and Id2+ CD25+ cells (ILC2Ps) could
be discriminated (Figure S2D), whereas Lin Id2+ IL-7Ra+
CD25 a4b7
+ cells differentiated only into Id2+ CD25+ cells
(ILC2Ps). Thus, Lin Id2+ IL-7Ra+ CD25 a4b7
+ cells can differ-
entiate in the bone marrow into lineage-specified ILC subsets
such as the ILC2P. In the small intestine, only few NKp46+
RORgt ILCs were found but these were substantially repre-
sented in the liver (Figure 2B). While the CLP generated both
Eomes+ cNK cells and an Eomes NKp46+ subset, Lin Id2+
IL-7Ra+ CD25 a4b7
+ cells exclusively gave rise to NKp46+ cells
that were Eomes negative (Figure 2B).
As CCR6+ ILC3s seed the intestine already during fetal devel-
opment, we investigated the fetal liver for an ILC progenitor.
Among Lin IL-7Ra+ Kitint (E15.5) fetal liver cells, we identified
integrin a4b7
+ Flt3 cells (Figure S2E). Within this subset, Id2+
CD25 cells and Id2+ CD25+ cells could be discriminated, the
latter constitute fetal RORgt+ ILC3s (Cherrier et al., 2012). Adop-
tive transfer of fetal liver Lin Id2+ IL-7Ra+ CD25 a4b7
+ Flt3
cells also generated all three ILC subsets (Figure S2F). We
wondered if such ILC progenitors could also be found in the
lamina propria of the small intestine. In adult small intestine,
virtually all Lin IL-7Ra+ cells expressed either RORgt, GATA-
3, or T-bet indicating that they are fully differentiated ILC subsets
(Figure S2G).
We further analyzed the proliferative potential of Lin Id2+ IL-
7Ra+ CD25 a4b7
+ cells and CLP by calculating their expansion
after transfer in vivo. Interestingly, both populations expanded
around 200-fold when transferred into alymphoid mice (Fig-
ure 2C). To further characterize the progeny of Lin Id2+ IL-
7Ra+ CD25 a4b7
+ cells and to firmly assign them to the various
characterized ILC lineages, we analyzed their cytokine profiles.
RORgt+ ILC3s produced high levels of IL-22 after stimulation
(Figure 2D). In contrast, KLRG1+ ILC2s produced IL-5 (Fig-
ure 2D). KLRG1 is a faithful marker of all GATA-3+ ILC2s (Hoyler
et al., 2012). Collectively, our data show that on a population
level in vivo, adult bone marrow and fetal liver Lin Id2+ IL-
7Ra+ CD25 a4b7
+ cells can differentiate into GATA-3+ ILC2s,
RORgt+ ILC3s, and an Eomes non-NK ILC subset but do not
give rise to Eomes+ cNK cells, T, B, or myeloid cells.
Finally, we used single-cell in vitro differentiation of Lin Id2+
IL-7Ra+ CD25 a4b7
+ cells on Notch ligand-expressing OP9
stroma cells (OP9-DL1) to determine if a single Lin Id2+ IL-
7Ra+ CD25 a4b7
+ cell could give rise to all ILC lineages or if
there is heterogeneity in our precursor pool. OP9-DL1 cells
were chosen because it was previously shown that the develop-
ment of adult RORgt+ cells and of ILCs from bone marrow pro-
genitors requires Notch ligands (Possot et al., 2011). We first
sought to determine the clonal frequency of ILC progenitor activ-
ity by in vitro limiting dilution assays. When limiting dilutions of
Lin Id2+ IL-7Ra+ CD25 a4b7
+ cells were cultured in the pres-
ence of SCF, IL-7, and IL-2, all plated cells had ILC progenitor
potential but did not give rise to B or T cells (Figure S2H). The
detection failure in the limiting dilution assay highly correlated
with the expected exponential curve (Figure 2E). When we
counted the total number of progeny from clonal wells after14 days, we calculated an average burst size of approximately
700–800 per cell, demonstrating the large proliferative capacity
of these cells when differentiating down the ILC lineage (Fig-
ure 2F). The burst size was highly reproducible among three
independent experiments (Figure 2F) and comparable to that
determined for the CLP (Karsunky et al., 2008).
To obtain firm evidence that a single Lin Id2+ IL-7Ra+ CD25
a4b7
+ progenitor cell could give rise to all three ILC lineages, we
seeded single progenitor cells into feeder-coated wells and
analyzed their differentation potential. ILC1s were defined as
NKp46+ T-bet+ RORgt cells, ILC2s as NKp46 GATA3high
RORgt cells, and ILC3s as NKp46+/ RORgt+ cells (Figure S2I).
In line with our in vivo transfer data, no cNK cells (NKp46+ T-bet+
Eomes+) were found (Figure 2G). Importantly, of all the wells
showing clonal growth, 38.5% contained two ILC lineages and
7.7% even 3 ILC lineages (Figure 2G). Similar results were
obtained when analyzing clonal wells in limiting dilution assays
(Figure S2J). Thus, Lin Id2+ IL-7Ra+ CD25 a4b7
+ cells can
differentiate as a population in vivo and on the clonal level
in vitro into ILC2s, ILC3s, and an Eomes ILC1 subset. We
conclude that while cNK cells are an ILC subset, they are not
derived from Lin Id2+ IL-7Ra+ CD25 a4b7
+ cells that are pro-
genitors to all other ILC populations. Given the striking similar-
ities between these ILC subsets and Th cell effector fates, we
will refer to Lin Id2+ IL-7Ra+ CD25 a4b7
+ cells as a common
progenitor to all helper-like ILCs (CHILP).
Identification of T-bet+ ILC1s Distinct from cNK Cells or
Plastic ILC3s
The finding that the CHILP did not generate Eomes+ cNK cells
but gives rise to an Eomes ILC population that expressed
NKp46 and NK1.1 (Figure 2B) raises the important question of
an ILC1 lineage distinct from cNK cells. Two lamina propria-resi-
dent, NKp46-expressing innate lymphocyte subsets have been
identified, NKp46+ RORgt+ ILC3s (Cella et al., 2009; Luci et al.,
2009; Sanos et al., 2009; Satoh-Takayama et al., 2008) and
NKp46+ RORgt ILCs (Figure 3A). We and others have provided
evidence that the NKp46+ RORgt population is composed of
cNK cells and NKp46+ ILC3s that have downregulated RORgt
expression (‘‘ex-RORgt+’’ ILC3s) (Bernink et al., 2013; Vonar-
bourg et al., 2010). Analysis of Rorc(gt)Gfp/+ and RORgt-fate
map (Rorc(gt)-CreTg x Rosa26RYfp/+) double-reporter mice re-
vealed that the population of NKp46+ RORgt ILCs is an aggre-
gate of various subsets, all of which expressed T-bet (Figure 3A).
It is composed of ‘‘ex-RORgt+’’ ILC3s (i.e., NKp46+ NK1.1high
RORgt RORgt-fm+ cells) and an RORgt-fm NK1.1high subset
that contained T-bet+ Eomes+ cNK cells (Figures 3A and S3A).
Given that the percentage of T-bet+ Eomes ILCs (ca. 80%)
cannot be accounted for by plastic ILC3s (ca. 30%), the
RORgt-fm NK1.1high subset contained an as of yet unidentified
non-NK, non-ILC3 T-bet+ Eomes ILC population.
To more definitively discern this non-NK, non-ILC3 T-bet+
Eomes ILC population among NKp46 and NK1.1-expressing
innate lymphocyte subsets, we generated EomesGfp/+ and
RORgt-fm double-reporter mice allowing us to separate cNK
cells (Eomes+ RORgt-fm) from the ILC3 lineage (Eomes
RORgt-fm+) (Figure 3B). We identified three distinct NKp46+
NK1.1+ populations resident in the lamina propria of the smallCell 157, 340–356, April 10, 2014 ª2014 Elsevier Inc. 343
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intestine (Figure S3B), all of which expressed T-bet (Figure 3C)
and additional activating NK cell receptors (Figure 3D). (1)
Eomes+ RORgt-fm cells represented cNK cells as they were
the only population substantially expressing inhibitory and stim-
ulatory Ly49 receptors (Figure 3E). (2) Eomes RORgt-fm+ cells
contained the various ILC3 subsets including NKp46+
‘‘ex-RORgt+’’ ILC3s. (3) Eomes RORgt-fm ILCs expressed
activating NK cell receptors (Figure 3D) but only a minor fraction
expressed Ly49 receptors (Figure 3E). Intriguingly, Eomes
RORgt-fm ILCs had the highest T-bet levels of all ILCs
(Figure 3C) and expressed markers found on other helper-like
ILC lineages such as IL-7Ra, Thy1 andKit (Figure 3F). In the small
intestine, the various NKp46+ NK1.1+ ILC populations could be
phenotypically separated by costaining with antibodies specific
for IL-7Ra and CD27 (Figure 3G). Thus, the NKp46+ lymphocyte
population (an operative definition of ‘‘NK cells’’) is diverse and
contains three distinct populations, cNK cells, NKp46+ ILC3s
(including ‘‘ex-RORgt+’’ ILC3s) and a previously unrecognized
T-bet+ Eomes ILC population. T-bet+ Eomes RORgt-fm cells
were also found in other organs but were best represented in
mucosal tissues whereas cNK cells dominated in lymphoid tis-
sues (Figures 3H, S3C, and S3D). Similar to NKp46+ ILC3s but
in contrast to cNK cells, Eomes T-bet+ ILCs expressed the IL-
7Ra and other markers commonly expressed by ILCs (Figures
3F and 3G) and could be generated from the CHILP (Figure 2).
We will, therefore, refer to the T-bet+ Eomes RORgt-fm ILCs
subset as ILC1s.
T-bet+ Eomes ILC1s Are a Stable Lineage Independent
of cNK Cells and ILC3s
In the liver, a NKp46+ NK1.1+ T-bet+ Eomes lymphocyte subset
has been identified, that, upon transfer, differentiated into T-bet+
Eomes+ cNK cells (Gordon et al., 2012). This rose the important
issue whether ILC1s are a stable lineage independent of cNK
cells or rather immature NK cells. To address this, we highly pu-
rified the three NKp46+ NK1.1+ populations from the small intes-
tinal lamina propria of EomesGfp/+ x RORgt-fm double-reporter
mice and adoptively transferred them into alymphoid mice.
Four weeks later, transferred ILC1s could be recovered from
small intestine and liver (Figure 4A). Interestingly, ILC1s re-
mained stably Eomes RORgt-fm NKp46+ NK1.1+ cells, while
cNK cells and NKp46+ NK1.1+ ILC3s remained Eomes+Figure 2. Lin Id2+ IL-7Ra+ CD25 a4b7
+ Cells Are Precursors to ILC2s
(A–D) The indicated highly purified cell populations from the bone marrow of Id2G
Rag/Il2rg/ mice (H-2d). Six to nine weeks after transfer, donor-derived (H-
C57BL/6 mice are shown for reference (right column).
(A and B) Donor-derived (H-2b) Lin (i.e., CD3CD19) cells were analyzed for the
(C) Expansion of the indicated precursor populations after transfer into Rag2/
(D) Small intestinal lamina propria leukocytes (LPL) were stimulatedwith either IL-2
production by donor-derived Lin (CD3 CD19) cells was assessed by intracell
each quadrant.
(E and F) Limiting dilution assay of Lin Id2+ IL-7Ra+ CD25 a4b7
+ cells. Serial dilut
IL-2, IL-7, and SCF. The cells were analyzed by flow cytometry and ILC lineages w
was plotted against percentage of wells without recovered lymphocytes (CD45+ c
for exponential regression. (F) Clonal burst sizes of three independent experimen
(G) Pie chart summarizes clonal differentiation potential of Lin Id2+ IL-7Ra+ CD25
IL-7 and SCF for 3 weeks. Wells containing lymphocytes (n = 52) were examined
Numbers represent percent of wells containing the indicated lineages.RORgt-fm cells or Eomes RORgt-fm+ cells, respectively (Fig-
ure 4A). The data demonstrate that ILC1s are a stable ILC lineage
and have no potential to differentiate into any of the other
NKp46+ NK1.1+ ILC subsets.
To more comprehensively investigate the lineage relationship
of the three NKp46+ populations in the small intestine, we per-
formed genome-wide transcriptome analysis and included cNK
cells from the bonemarrow as a bona fide NK cell reference pop-
ulation. For each subset, four to five independent samples were
analyzed and found to cosegregate in a principal component
analysis (PCA) (Figure 4B). Consistent with a gene expression
signature common to helper-like ILCs, the PCA indicated closer
relationship of ILC1s to NKp46+ NK1.1+ ILC3s than to cNK cells
from the small intestine or bonemarrow (Figure 4B). Further anal-
ysis for highly expressed genes identified a core program of
6,680 genes common to all ILC subsets (Figure 4C). In addition,
gene sets specific or common to the four ILC subsets could be
identified (Figure 4C). To gain further insights into the biological
processes controlled by differential gene expression among
ILC1s and cNK cells, we performed gene set enrichment analysis
(GSEA). In cNK cells, gene sets for cell-cycle control and E2F
were significantly enriched (Figures S4A and S4B). On the other
hand, ILC1s depicted significant enrichments of gene clusters
for chemokine and cytokine activity (Figures S4C and S4D).
Analysis of selected genes differentially expressed among the
four cell subsets based on robust differences in expression, the
involvement in immune processes, and the GSEA analysis re-
vealed striking differences between cNK cells and ILC1s in the
expression of chemokine and cytokine receptors. For example,
Ccr7 and S1pr5 required for homing to and egress from second-
ary lymphoid organs, respectively, were highly expressed by
cNK cells but not by ILC1s (Figure 4D). ILC1s, in contrast, ex-
pressed high levels of Cxcr3, Cxcr6, and Ccr9, all of which are
involved in lymphocyte migration to tissues (Figure 4D). Another
striking cluster of difference were cell adhesion molecules with
cNK cells expressing Sell (encoding CD62L or L-selectin), Itga2
(encoding CD49b), Itgam (encoding CD11b), and Itga4 (encod-
ing CD49d), whereas ILC1s were Itga1 (encoding CD49a) high
(Figure 4D), a pattern that was confirmed by flow cytometry (Fig-
ure S4E). Interestingly, such differential expression of integrins
reflected preferences in localization of cNK cells (lymphoid-resi-
dent) versus ILC1s (tissue-resident). NK cells, but not ILC1s, ILC3s, and a Non-NK ILC1 Population
fp/+ mice (H-2b) were adoptively transferred into sublethally irradiated BALB/c
2b) cells were analyzed by flow cytometry. Leukocyte populations of control
indicated molecules. Numbers represent percent of cells in the indicated area.
Il2rg/ hosts.
3 and IL-1b or with PMA and ionomycin in the presence of Brefeldin A. Cytokine
ular staining and flow cytometry analysis. Numbers indicate percent of cells in
ions of 30–0.5 cells/well were cultured onOP9-DL1 feeder cells for 14 days with
ere characterized as shown in Figure S2I. (E) Number of cells seeded per well
ells). Values are mean ± SEM from three independent experiments, R2 = 0.9519
ts were calculated based on limiting dilution assay.
 a4b7
+ cells which were single-cell sorted onto feeder cells and cultivated with
for the presence of ILC1, ILC2, and ILC3 by flow cytometry (see Figure S2I).
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Figure 3. NKp46+ NK1.1+ Lymphocytes in the Lamina Propria Consist of Three Distinct ILC Subsets
(A) Flow cytometry analysis of small intestinal LPL from RorcGfp/+ x Rorc(gt)-CreTg x Rosa26RYfp/+ double-reporter mice for RORgt (GFP) and NKp46. The
indicated populations of cells were further analyzed for NK1.1 and RORgt-fm (YFP) expression (top) or for the expression of T-bet and Eomes (bottom). Plots were
electronically gated on Lin CD45+ lymphocytes.
(legend continued on next page)
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expressed cell surface receptors such as Ly49s and Klrg1 and
cytotoxic effector molecules (i.e., Prf1, Gzmk) (Figure 4D). NK
cells expressed higher levels of the transcription factors Eomes,
Nfil3, and Tcf7, whereas ILC1s were found to express signifi-
cantly higher levels of Tbx21 (the gene encoding T-bet) (Figures
3C and 4D) and Id2 (Figure 4D and S4F). Interestingly, ILC1s ex-
pressed higher levels of Il12rb1 (encoding the b1 chain of the IL-
12 receptor), suggesting that ILC1s may be highly responsive to
IL-12, a notion that will be experimentally tested later.
ILC1s Require IL-15, but Not IL-7, for Maintenance and/
or Differentiation
Conventional NK cells express CD122 (the IL-2/IL-15 receptor b
chain), but not IL-7Ra, and cNK cells require IL-15, but not IL-7,
for their development and/or maintenance (Kennedy et al.,
2000). ILC2s and ILC3s express the IL-7Ra and require IL-7
signaling for differentiation and/or maintenance (Hoyler et al.,
2012; Moro et al., 2010; Neill et al., 2010; Vonarbourg et al.,
2010). Interestingly, ILC1s similar to NKp46+ NK1.1+ ILC3s coex-
pressed IL-7Ra and intermediate levels of CD122 (Figure 4E). It
should be noted that plasticity within the ILC3 lineage correlated
with changes in IL-7Ra and CD122 expression. While NKp46
ILC3s are IL-7Rahigh and CD122 (Satoh-Takayama et al.,
2010), NKp46+ NK1.1+ ILC3s enriched in ‘‘ex-RORgt+’’ cells had
downregulated IL-7Ra and upregulated CD122 (Figure S4G).
We tested representation of the NKp46+ NK1.1+ ILC subsets in
mice genetically deficient for the Il15 or the Il7ra gene. ILC1s
were normally represented in mice lacking the IL-7Ra whereas
NKp46+ NK1.1+ ILC3s were dramatically reduced (Figures 4F,
4G,S4H, andS4I), reflecting the reductionof itsNKp46 ILC3pro-
genitors (Vonarbourg et al., 2010). Consistent with previous data
(Vonarbourg et al., 2010), cNK cells are overrepresented in
Il7ra/ mice, leading to radical shifts in relative population sizes
(Figures 4F, 4G, S4H, and S4I). Strikingly, ILC1s similar to cNK
cells required IL-15 for their development ormaintenance (Figures
4F, 4G, S4H, and S4I). Interestingly, while RORgt+ ILC3s are inde-
pendent of IL-15 (Figure S4J) (Sanos et al., 2009; Satoh-Ta-
kayama et al., 2008), ‘‘ex-RORgt+’’ ILC3s required IL-15 for main-
tenance (Figures4F, 4G,S4H, andS4I),which correlateswith their
upregulated expression of CD122 and downregulation of IL-7Ra.
Our data expose an important switch in cytokine dependency
within the ILC3 lineage and shows cell stage-specific roles of IL-
15 and IL-7R signaling for the maintenance of ILC lineages.
ILC1sStrictly Require T-bet andArePartially Dependent
on NFIL3 for Development
The ILC2 and ILC3 lineages require their lineage-specifying tran-
scription factors, GATA-3 and RORgt, respectively, for develop-(B–H) Flow cytometry analysis of NKp46+ NK1.1+ lymphocytes isolated from the
Rorc(gt)-CreTg xRosa26RYfp/+ (from now on referred to as EomesGfp/+ x RORgt-fm
of cells per quadrant. (B) Eomes (GFP) and RORgt-fm (YFP) expression in Lin NK
n = 3) of T-bet signal in the indicated cell populations. (D) NKG2D and CD160 expr
(FMO) control (open). (E) Ly49 expression by the various Lin NKp46+ NK1.1+ lym
lymphocyte subsets was analyzed by flow cytometry. Expression of the indicate
grams). (G) Indicated populations of cells gated for CD27 and IL-7Ra were anal
RORgt-fm (YFP) analysis in NKp46+ NK1.1+ lymphocytes.
Data are representative of two or three independent experiments.ment and/or maintenance. We analyzed expression of various
transcription factors required for ILC development in NKp46+
NK1.1+ ILC subsets and found that they expressed high levels
of Tbx21,Gata3, and Nfil3 (Figure 5A), the latter is a transcription
factor believed to be exclusively required for the development of
cNK cells (Gascoyne et al., 2009; Kamizono et al., 2009). ILC1s
virtually lacked expression of Eomes or Rorc, which were selec-
tively expressed by cNK cells or NKp46+ ILC3s, respectively
(Figure 5A).
To gain an understanding of which transcription factors are
required for the differentiation of ILC1s, we analyzed mice
genetically deficient for various ILC lineage-specifying transcrip-
tion factors. In Tbx21/ mice, ILC1s (for gating see Figure 3G)
were lacking, demonstrating that ILC1 differentiation is strictly
T-bet-dependent (Figures 5B, 5C, and S5A). As previously
described (Klose et al., 2013; Rankin et al., 2013), ILC3s required
T-bet to differentiate into NKp46+ ILC3s (Figures 5B, 5C and
S5A). In contrast, intestinal cNK cells can develop in the absence
of T-bet (Gordon et al., 2012; Townsend et al., 2004) and were
even overrepresented in Tbx21/ mice. T-bet expression is a
cell intrinsic requirement for ILC1 differentiation as revealed by
mixed bone marrow chimeras in which only T-bet-expressing
hematopoietic precursors were able to generate ILC1s and
NKp46+ NK1.1+ ILC3s (Figure S5B,C). Thus, intestinal ILC1s
are a T-bet-dependent ILC lineage.
RORgt is a transcription factor required for ILC3 develop-
ment (Eberl et al., 2004). Mice genetically deficient for RORgt
(Rorc(gt)Gfp/Gfp) showed normal development of both cNK cells
and ILC1s whereas NKp46+ NK1.1+ ILC3s were reduced (Fig-
ures 5D, 5E, and S5D). Eomes and NFIL3 are transcription fac-
tors required for the development of cNK cells (Gascoyne
et al., 2009; Gordon et al., 2012; Kamizono et al., 2009). Indeed,
mice with a mesenchymal deletion of Eomes or Nfil3 lacked all
cNK cells (Figures 5F–5I, S5E, and S5F). Strikingly, Nfil3D/D
mice had reduced numbers of all NKp46+ NK1.1+ ILCs including
ILC1s and ILC3s (Figures 5H, 5I, and S5F). Thus, our data reveal
an intriguing and previously unrecognized requirement of
NFIL3 for the generation of ILC1s and NKp46+ NK1.1+ ILC3s.
Consistent with very low level Eomes expression in ILC1s
and NKp46+ NK1.1+ ILC3s (Figure 5A), Eomes-deficient mice
had normal development of these ILC subsets (Figures 5F, 5G
and S5E).
GATA-3 Is Required for the Development or
Maintenance of ILC1s
Interestingly, together with NKp46+ NK1.1+ ILC3s, ILC1s ex-
pressed substantial levels of the transcription factor GATA-3
(Figure 5A). Experiments with inducible deletion of Gata3 in allsmall intestinal lamina propria (B–G) or indicated tissues (H) of EomesGfp/+ x
) mice. Gating strategy is shown in Figure S3A. Numbers represent percentage
p46+ NK1.1+ lymphocytes. (C) Mean fluorescence intensity (MFI) (mean ± SD;
ession. Indicated markers (gray) were compared to the fluorescenceminus one
phocyte subsets. (F) IL-7Ra, Kit, and Thy1 expression by Lin NKp46+ NK1.1+
d markers (gray histograms) was compared to the FMO control (open histo-
yzed for Eomes (GFP) and RORgt-fm (YFP). (H) Eomes (GFP) expression and
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Id2-expressing cells revealed that GATA-3 is strictly required for
the maintenance of ILC2s, but not of ILC3s (Hoyler et al., 2012).
Recent data revealed that deletion of Gata3 in all hematopoietic
cells leads to the absence of both ILC2s and ILC3s whereas cNK
cell development is nomal (Serafini et al., 2014; Yagi et al., 2014).
To test the role of GATA-3 for ILC1s, we generated mice with a
deletion of Gata3 in all NKp46+ cells. In these mice, cells with
Cre activity (i.e., deletion ofGata3) can be visualized by a fluores-
cent reporter (YFP). Interestingly, deletion of Gata3 in NKp46+
cells (the Ncr1 gene encodes for NKp46) resulted in the absence
of intestinal ILC1s, whereas cNK cells and ILC3s were not
affected (Figures 5J and 5K; for gating see Figure 3G). Thus,
maintenance or differentiation of ILC1s requires T-bet, NFIL3,
and GATA-3. We also deleted GATA-3 in progenitor cells using
Id2-driven Cre expression which led to substantial reduction in
ILC1s (Figure S5G). Thus, GATA-3 may be required for differen-
tiation and maintenance of ILC1s, similarly to ‘‘thymic NK cells’’
(Vosshenrich et al., 2006). However, ILC1s are distinct from
‘‘thymic NK cells’’ because ILC1s develop independently of IL-
7R signaling and do not express intracellular CD3ε (Figure S5H)
(Stewart et al., 2007; Vosshenrich et al., 2006).
The Bone Marrow Contains Immature ILC1s
Eomes RORgt-fm ILC1s were also substantially represented
in the bonemarrow ofmice (Figure 3H) where they can be pheno-
typically discriminated as Eomes IL-7Ra+ CD49a+ cells (Figures
S6A and S6B). In the past, ‘‘immature NK cells’’ were defined as
NKp46+ NK1.1+ IL-7Ra+ cells (Di Santo, 2006; Fathman et al.,
2011). Our data now demonstrate that this population is hetero-
geneous as an Eomes and an Eomes+ subset could be discrim-
inated (Figure 6A). Eomes CD49a+ IL-7Ra+ cells (for gating see
Figures S6A and S6B) entirely depended on T-bet for develop-
ment (Figures 6A and 6B) but were independent of Eomes
(Figures 6C and 6D). In contrast, the IL-7Ra+ Eomes+ CD49a
subset required Eomes but was independent of T-bet. Similar
to ILC1s in the small intestine, differentiation of bone marrow
IL-7Ra+ CD49a+ ILC1s required NFIL3 (Figures 6E–6G) and
GATA-3 (Figures 6H and 6I). Thus, the population of bone
marrow ‘‘immature NK cells’’ contains an Eomes IL-7Ra+
CD49a+ subset that shares transcription factor expression and
developmental requirements with ILC1s.
Ourdata suggest thatNKp46+NK1.1+EomesCD49a+ IL-7Ra+
cells in the bone marrow are not iNK cells but are bone-marrow-
resident, immature ILC1s. To further test this notion, we culturedFigure 4. Transcriptome Analysis of NKp46+ NK1.1+ ILC Subsets
(A) Indicated cell subsets were sorted from the small intestine of EomesGfp/+ x RO
After four weeks, cells were purified from the lamina propria of the small intestin
tronically gated on donor-derived (H-2b) NKp46+ NK1.1+ lymphocytes.
(B) Principal component analysis. The first three principal components were plotte
NK1.1+ ILC3, cNK [SI]) or bone marrow (cNK [BM]).
(C) Venn diagram. All unique genes with expression valueR 5 were extracted an
(D) Heat map of selected genes differentially expressed among the indicated c
involvement in immune processes and the GSEA analysis.
(E) Analysis for IL-7Ra and CD122 expression by the indicated ILC subsets (see
(F) NKp46 and NK1.1 expression by Lin small intestinal LPL from the indicated
NKp46+ NK1.1+ ILCs (bottom).
(G) Absolute cell numbers (mean ± SEM; n = 5–6) of the indicated cell subsets. *
Gene array was performed with four to five independent biological replicates perEomes RORgt-fm and Eomes+ RORgt-fm cells isolated from
EomesGfp/+ x RORgt-fm double-reporter mice in vitro. After
7 days, progeny of both cell types remained NKp46+ NK1.1+ (Fig-
ures 6J and S6C). Eomes RORgt-fm cells had no potential to
differentiate into cNK or RORgt-fm+ cell but stably remained
Eomes RORgt-fm ILC1s. Similarly, NKp46+ NK1.1+ Eomes+
RORgt-fm cells differentiated into cNK cells and could not be di-
verted to the ILC1 or ILC3 lineages (Figures 6J and S6C).
We further probed the developmental potential of these
populations by transfer into alymphoid (Rag2/ Il2rg/) mice.
As expected, transfer of a CLP population generated ILC1s,
cNK cells, and NKp46+ NK1.1+ ILC3s (Figure 6K). Consistent
with our in vitro data, NKp46+ NK1.1+ Eomes RORgt-fm cells
only generatedmature ILC1s (Figures 6L, 6M, and S6D). Transfer
of NKp46+ NK1.1+ Eomes+ RORgt-fm cells led to the genera-
tion of cNK cells. Thus, our data demonstrate that the NKp46+
NK1.1+ IL-7Ra+ population in the bone marrow, previously
believed to represent iNK cells, is a mixed population in which
the Eomes CD49a+ subset represents immature ILC1s and
the Eomes+ CD49a subset embodies iNK cells.
ILC1s Protect against Intracellular Infections
We assessed the functional profile of ILC1s in comparison to
cNK cells and NKp46+ NK1.1+ ILC3s. Consistent with our gene
array analysis (Figure 4), cNK cells expressed high levels of
genes required for cell-mediated cytotoxicity whereas ILC1s
and ILC3s showed only low level expression (Figure S7A).
Accordingly, ILC1s and ILC3s degranulated less compared to
cNK cells when stimulated with PMA and ionomycin (Figure S7B)
or when coincubated with a prototypical NK target cell (YAC-1)
(Figure S7C).
All intestinal NKp46+ NK1.1+ ILC subsets showed high level
Ifng gene expression (Figure S7D). Interestingly, only ILC1s
also expressed high levels of Tnf. Indeed, ILC1s were avid
coproducers of IFN-g and TNF, whereas cNK cells produced
mainly IFN-g (Figures 7A, S7E, and S7F). In line with our gene
array data, all ILC1s but only a small subset of cNK cells ex-
pressed the IL-12RB1 chain (Figure 7B). Reflecting constitutive
expression of both IL-12R chains, only ILC1s responded with
vigorous IFN-g production to stimulation with IL-12 (Figures 7C
and S7G).
We tested the role of ILC1s in an intracellular infection model
by orally infecting mice with the parasite T. gondii. T. gondii
infection seemed a suitable model because it requires strongRgt-fm mice (H-2b) and injected i.v. into BALB/c Rag2/ Il2rg/mice (H-2d).
e and analyzed by flow cytometry for the indicated proteins. Plots were elec-
d for the indicated cell subsets isolated from the lamina propria (ILC1, NKp46+
d plotted. Numbers represent numbers of genes.
ell subsets. Genes were selected based on the difference in expression, the
Figure S3B) from EomesGfp/+ x RORgt-fm mice.
mouse strains (top). Expression of CD27 and Eomes by electronically gated
p <0.05; **p <0.01 and ***p <0.001; ns, not significant.
group. Other data are representative of two to three independent experiments.
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Figure 5. ILC1 Differentiation Requires T-bet, NFIL3, and GATA-3
(A) Expression of the indicated genes was analyzed by qRT-PCR using RNA from highly purified ILC subsets.
(B–I) Leukocyteswere purified from the laminapropria ofwild-type orTbx21/ (B andC),Rorc(gt)Gfp/Gfp (D andE),EomesD/D (F andG), orNfil3D/Dmice (H and I). (B,
D, F, and H) Plots were electronically gated on NKp46+ NK1.1+ lymphocytes and further analyzed for CD27 and IL-7Ra expression. Numbers represent percent of
cells in gated area. (C, E, G, and I) Absolute cell numbers (mean ± SD; nR 3) of the indicated cell subsets in the small intestine of the indicated mouse strains.
(J and K) Leukocytes were purified from the lamina propria of Gata3flox/flox x Rosa26RYfp/+ or Ncr1-iCreTg x Gata3fl/fl x Rosa26RYfp/+ mice. (J) Plots were elec-
tronically gated on NKp46+ NK1.1+ lymphocytes and further analyzed for the indicated markers. (K) Relative numbers (mean ± SD; n = 4) of the indicated cell
subsets. *p <0.05; **p <0.01 and ***p <0.001; ns, not significant.
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IL-12-induced type 1 immunity (IFN-g-dependent) and previous
data have involved NKp46+ cells in the innate control of the para-
site (Denkers et al., 1993; Gazzinelli et al., 1993; Suzuki et al.,
1988). Significantly, ILC1s were the main producers of IFN-g
and TNF in response to T. gondii infection, whereas cNK cells
and NKp46+ NK1.1+ ILC3s only contributed to a smaller extent
(Figures 7D–7F). Consistent with the role of ILC1s as the main
IFN-g producers, mice lacking T-bet expression had virtually
no IFN-g production in response to T. gondii infection (Figure 7G
and S7H) and failed to control parasite replication (Figure 7H).
NKp46+ cells were shown to be involved in the recruitment of in-
flammatory monocytes (Schulthess et al., 2012) that are required
to control T. gondii infection (Dunay et al., 2008). Tbx21/
mice that lack ILC1s failed to recruit inflammatory monocytes
(CD11b+ Ly6Chigh cells) (Figures S7I and S7J).
Alymphoid mice (Rag2/ Il2rg/ mice) were unable to pro-
duce IFN-g in response to Toxoplasma infection (Figure S7K)
and did not control Toxoplasma replication (Figure 7I). Transfer
of ILC1s led to production of IFN-g and TNF (Figure S7K), result-
ing in substantial reduction of Toxoplasma titers (Figure 7I).
Furthermore, attraction of inflammatory monocytes was sub-
stantially enhanced after transfer of ILC1s (Figures S7L and
S7M). Collectively, our data provide evidence that ILC1s can
coordinate a type 1 immune response sufficient for the innate
control of an intracellular infection.
DISCUSSION
An Id2-Expressing Progenitor to All IL-7Ra+ Helper-like
ILC Lineages
ILCs are of the lymphoid lineage as they can be generated from
the CLP (Possot et al., 2011). The transcriptional regulator Id2
has emerged as a central regulator of ILC fate (Hoyler et al.,
2012; Moro et al., 2010; Yokota et al., 1999). Mice deficient
for Id2 show largely normal development of T and B cells but
lack all ILC subsets. Interestingly, early B cell factor 1 (EBF1), a
pioneer transcripton factor required for the specification of the
B cell lineage, is a potent repressor of Id2 (Treiber et al., 2010).
Repression of Id2 allows for unrestrained activity of the E protein
E2A, required for B cell development. Deletion of Ebf1 in early
B cell progenitors reprogrammed B cells (that already showedFigure 6. Identification of an Immature ILC1 Subset in the Bone Marro
(A–D) Leukocytes were isolated from the bone marrow of Tbx21+/+ and Tbx21/
gated NKp46+ NK1.1+ ILCs were further analyzed for the indicated markers. (B a
(E–G) Leukocytes were purified from the bone marrow of Nfil3+/+ and Nfil3D/D mic
and IL-7Ra expression (E). Percentages (F) or absolute (G) cell numbers (mean ±
(H and I) Leukocytes were isolated from bone marrow ofGata3fl/fl x Rosa26RYfp/+
NK1.1+ ILCs were further analyzed for the indicated markers. (I) Percentage (me
(J) Bone marrow, immature ILC1s (CD49a+ IL-7Ra+ Eomes NKp46+ NK1.1+) or
mice were sorted to high purity and cultured in medium containing IL-2, IL-7 an
Electronically gated NKp46+ NK1.1+ cells were analyzed for Eomes (GFP) and R
(K) Highly purified bone marrow CLP populations from EomesGfp/+ x RORgt-fm m
were isolated from the indicated organs and analyzed by flow cytometry for th
NKp46+ NK1.1+ lymphocytes.
(L and M) The indicated populations highly purified from the bone marrow of E
recipients. Four weeks after transfer, lymphocytes from the lamina propria (L) an
electronically gated on NKp46+ NK1.1+ cells.
Data are representative of two to three independent experiments. *p <0.05; **p <
352 Cell 157, 340–356, April 10, 2014 ª2014 Elsevier Inc.B cell receptor rearrangements) into ILCs which correlated with
derepression of Id2 expression (Nechanitzky et al., 2013).
Thus, high level expression of Id2 can reprogram lineage-spec-
ified B cells to the ILC fate indicating that Id2 is an important
knot in the transcriptional networks specifying the ILC lineage.
We have identified a Lin Id2+ IL-7Ra+ CD25 a4b7
+ Flt3
bone marrow and fetal liver-resident population as a progenitor
to all helper-like, IL-7Ra+ ILC lineages, but not to IL-7Ra cNK
cells. While Lin a4b7
+ Flt3 RORgt fetal liver cells are progen-
itors to ILC3s that sequentially initiate expression of Id2 and
RORgt (Cherrier et al., 2012; Possot et al., 2011), we now show
that Id2+ a4b7
+ Flt3 RORgt fetal liver cells have the potential
to differentiate into all three helper-like ILC subsets. The CHILP
population consisted of a PLZF+ and a PLZF subset and
PLZF is an Id2-controlled gene indicating that the PLZF+ subset
may be the progeny of PLZF CHILP (Verykokakis et al., 2013).
Indeed, PLZF-expressing ILC progenitors had a more restricted
differentiation potential in that they gave rise to ILC1s, ILC2s, and
CCR6 ILC3s, but not to CCR6+ (LTi-like) ILC3s (Constantinides
et al., 2014).
ILC1s Are T-bet-Dependent ILCs Distinct of cNK Cells
The ILC1 lineage is not well defined but has been predicted to
require T-bet for lineage specification and function and produce
‘‘type 1’’ cytokines such as IFN-g (Spits et al., 2013). We identify
an IL-7Ra+ NK cell receptor-expressing ILC lineage that required
T-bet for lineage specification but was independent of Eomes,
which is required for the development of cNK cells (Gordon
et al., 2012). Recently, an NK cell receptor-expressing innate
lymphocyte subset located within the intestinal epithelium has
been referred to as intraepithelial ILC1-like cells (Fuchs et al.,
2013). While these cells express T-bet and seem to be reduced
in T-bet-deficient mice, they differ in various aspects from ILC1s.
Intraepithelial ILC1-like cells did not express the IL-7Ra andwere
independent of IL-15 for development and/or maintenance.
Similar to cNK cells, intraepithelial ILC1-like cells expressed
Eomes and required NFIL3 for their development.
T-bet is also expressed by RORgt+ ILC3s. A series of recent
reports documented that a subset of CCR6/low ILC3s, all of
which express RORgt, follow a differentiation program in which
they first upregulate T-bet, then acquire NK cell receptors suchw
(A and B) or Eomes+/+ and EomesD/D (C and D) mice. (A and C) Electronically
nd D) Percentage (mean ± SD; n = 3–4) of the indicated ILC subsets.
e. Electronically gated NKp46+ NK1.1+ lymphocytes were analyzed for CD49a
SD; n = 3) of immature ILC1s (CD49a+ IL-7Ra+ cells).
or Ncr1-iCreTg xGata3fl/fl x Rosa26RYfp/+mice. (H) Electronically gated NKp46+
an ± SD; n = 3) of the indicated cell subsets.
cNK (CD49a IL-7Ra Eomes+ NKp46+ NK1.1+) from EomesGfp/+ x RORgt-fm
d IL-15. After 7 days, cells were harvested and analyzed by flow cytometry.
ORgt-fm (YFP). Numbers represent percentage of cells in quadrant.
ice were injected i.v. into BALB/c Rag2/ Il2rg/mice. After four weeks, cells
e indicated proteins. Plots were electronically gated on donor-derived (H-2b)
omesGfp/+ x RORgt-fm mice were injected i.v. into BALB/c Rag2/ Il2rg/
d liver (M) were analyzed by flow cytometry. Donor-derived cells (H-2b) were
0.01 and ***p <0.001; ns, not significant.
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Figure 7. ILC1s Provide Innate Protection against the Intracellular Parasite T. gondii
(A) Small intestinal LPL from EomesGfp/+ x RORgt-fmmice were stimulated with PMA and ionomycin and the expression of IFN-g and TNF by the various NKp46+
NK1.1+ ILC was determined. Numbers represent percentage of cells per quadrant.
(B) Expression of Eomes and IL-12Rb1 by electronically gated NKp46+ NK1.1+ lymphocytes isolated from the small intestine. Numbers represent percentage of
cells in quadrants.
(C) Small intestinal LPL from EomesGfp/+ mice were stimulated with IL-12. After 4 hr, IFN-g production by NKp46+ NK1.1+ ILCs was determined. Numbers
represent percentage of cells per quadrant.
(D–F) EomesGfp/+ x RORgt-fm mice were orally infected with T. gondii. After 4 days, NKp46+ NK1.1+ ILCs were analyzed for Eomes (GFP) and IFN-g or TNF
expression. Numbers represent percentage of cells per quadrant. Percentage (mean ± SD; n = 3) of IFN-g (E) or TNF (F) producing cells within the indicated ILC
subsets.
(G and H) Tbx21+/+ and Tbx21/mice were orally infected with T. gondii. Lymphocytes from the small intestine were isolated 5 days after infection. Electronically
gated NKp46+ NK1.1+ ILCs were analyzed for Eomes and IFN-g expression (G). T. gondii burden in the small intestine were determined by qPCR eight days after
infection (mean ± SD; n = 4–5) as the ratio of T. gondii gene B1 and mouse argininosuccinate lyase (Asl) gene (H).
(legend continued on next page)
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as NKp46 and then downregulate RORgt, allowing for pheno-
typic and functional plasticity (Bernink et al., 2013; Klose et al.,
2013; Rankin et al., 2013). These T-bet+ RORgt+ ILC3s require
RORgt for their development and are independent of T-bet for
lineage specification. Human ILC3s can also convert into
‘‘ILC1-like’’ cells but there may also be bona fide ILC1 popula-
tions distinct of the ILC3 lineage (Bernink et al., 2013; Fuchs
et al., 2013). Thus, T-bet+ RORgt+ ILC3s belong to the ILC3 line-
age and should not be included into group 1 ILCs.
Are cNKCells a LineageSeparate fromHelper-like ILCs?
Conventional NK cells have been categorized as ILC1s, but they
only partially fulfill the ILC1 criteria as they do not depend on T-
bet for lineage specification (Townsend et al., 2004). Our data
now reveal that the population of NKp46+ NK1.1+ ILCs (so far,
an operative definition of NK cells) is more diverse than previ-
ously appreciated. In mucosal organs, NKp46+ NK1.1+ ILCs
consist of cNK cells, ILC1s and NKp46+ NK1.1+ ILC3s, the latter
population is enriched for ‘‘ex-RORgt+’’ ILC3s. Remarkably, the
CHILP did not give rise to cNK cells indicating that cNK cells
differentiate down a separate lineage. Our genome-wide gene
expression data underscore this notion as NKp46+ NK1.1+
ILC3s and ILC1s are more closely related to themselves than
to cNK cells. Previous data suggested that lineage specification
of the NKP is Id2-independent and that Id2 may be upregulated
later at the immature NK cell stage (Boos et al., 2007), a finding
supported by our data showing that only a small subset of
rNKP express Id2. However, recent data challenged that notion
by identifying an Id2+ Flt3 progenitor to NK-cell-receptor-ex-
pressing lymphocytes. It was not investigated if the progeny of
this cell type are Eomes-expressing cNK cells or rather T-bet+
ILC1s, both of which express various NK cell receptors (Carotta
et al., 2011). Coexpression of T-bet and Eomes as seen in cNK
cells has also been observed for CD8 T cells (Pearce et al., 2003).
Recently, it has become clear that GATA-3 is required for
development and maintenance of the various IL-7Ra+ ILC line-
ages (Hoyler et al., 2012; Serafini et al., 2014), but not for IL-7Ra
cNK cells (Vosshenrich et al., 2006; Yagi et al., 2014). Previously,
unconventional NK cell subsets have been discovered. Thymic
NK cells are GATA-3-dependent, a requirement which is shared
by ILC1s (Vosshenrich et al., 2006). However, thymic NK cells
required IL-7 for development, whereas ILC1s required IL-15.
The effects of GATA-3 deletion are dependent on the differenti-
ation stage of ILCs. Deletion of GATA-3 in differentiated NKp46+
cells affected only ILC1s whereas NKp46+ NK1.1+ ILC3s and
cNK cells were unaffected. GATA-3 deficiency in all Id2-express-
ing, ILC-specified cellsmainly affected themaintenance of ILC2s
(Hoyler et al., 2012; Yagi et al., 2014). Constitutive GATA-3 dele-
tion in all hematopoietic cells affected all IL-7Ra+ ILCs, but not
cNK cells (Vosshenrich et al., 2006), suggesting that the differen-
tiation program of IL-7Ra+ helper-like ILCs, but not of IL-7Ra
cNK cells, may require GATA-3 (Figure 7J). Collectively, these
data indicate that cNK cells are better described as cytotoxic(I)Rag2/ Il2rg/mice were reconstituted by adoptive transfer of highly purified
liver was determined by qPCR (mean ± SD; n = 5–7) at day 6 after infection.
(J) Model of ILC differentiation.
Data are representative of two to three independent experiments. *p <0.05; **p <
354 Cell 157, 340–356, April 10, 2014 ª2014 Elsevier Inc.ILCs, developmentally separate from the cytokine-producing
helper-like ILC populations (Figure 7J). The identification of the
CHILP will now allow for an unprecedented interrogation of the
signals driving ILC fate decisions.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were purchased from Janvier Laboratories. Genetically modi-
fied mouse strains were bred locally. All animal experiments were approved
and performed in accordance with the guidelines of the local animal care
and use committees and the Regierungspra¨sidium Freiburg and Magdeburg.
Adoptive Transfers In Vivo
For adoptive transfer experiments, highly purified (>98%) cell populations
were injected i.v. into Rag2/ Il2rg/ mice, some of which were previously
irradiated with 4.5 Gy. Mice were kept under SPF conditions and if they
were irradiated, the drinking water was supplemented with antibiotics.
Toxoplasma Gondii Infections
Micewere infected by oral gavagewith 10 or 50 T. gondii cysts, similarly as pre-
viously described (Dunay et al., 2008). For determination of parasite burden,
whole-organ DNA was isolated and expression of T. gondii B1 gene relative
tomouse argininosuccinate lyase (Asl) genewasmeasured by semiquantitative
real-timePCR (for primer information, seeExtendedExperimentalProcedures).
Isolation of Lymphocytes and Flow Cytometry
Leukocytes from the small intestinal lamina propria were isolated as described
previously (Sanos et al., 2009). Detailed protocols on cell isolation from the
different organs can be found in the Extended Experimental Procedures. For
flow cytometry staining, cells were preincubated with a blocking antibody
against CD16/32. For CHILP stain, lineage was excluded using antibodies
against CD3, CD5, CD19, B220, Gr-1, NK1.1, and TER-119. For all other
stains, lineage mix contained CD3, CD5, CD19, and Ly6G unless otherwise
indicated. A detailed list of antibodies and clones used can be found in the
Extended Experimental Procedures. For cytokine staining, cells were incu-
bated for 4 hr at 37C in the presence of GolgiStop or Brefeldin A and stimu-
lating reagents where indicated, staining was performed after fixation using
Cytofix/Cytoperm (BD Biosciences) according to the manufacturer’s instruc-
tions. Transcription factor staining was carried out with the FoxP3 staining
kit (eBioscience) according to the manufacturer’s instructions. Cells were
analyzed on a FACS Canto II or LSR Fortessa (both BD Biosciences) or sorted
on a BD FACS Aria III.
Microarray and qRT-PCR
RNA from highly purified sorted cells was extracted using Trizol and phenol/
chloroform extraction for qRT-PCR. For microarray, RNA was isolated using
the RNeasy Micro Kit (QIAGEN) and samples with an average RIN of 9.7
were amplified with Ovation Pico WTA V2 kit (Nugen) according to the manu-
facturer’s protocol. Hybridization was carried out on an Affymetrix GeneChip
ST 2.0 and data were computed using R version 2.15.1.
Limiting Dilution and Clonal Differentiation In Vitro
Limiting dilution was performed by culturing CHILP in serial dilutions (30–0.5
cells/well) onmitomycin C-treatedOP9-DL1 feeder cells for twoweeks in com-
plete RPMI and in the presence of IL-2 (10 ng/ml), IL-7, and SCF (20 ng/ml
each), followed by flow cytometry analysis. For clonal differentiation, CHILP
were single-cell sorted onto inactivated OP9-DL1 feeders and cultured for
3 weeks with IL-7 and SCF (20 ng/ml each), after which they were analyzed
by flow cytometry.ILC1s or left untreated. Mice were infected with T. gondii. T. gondii burden in the
0.01 and ***p <0.001; ns, not significant.
Accession numbers
The ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) accession number for
the gene array data reported in this paper is E-MTAB-2428.SUPPLEMENTAL INFORMATION
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